cryptolepine has been researched along with neocryptolepine in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Cimanga, K; De Bruyne, T; Pieters, L; Turger, CA; Vlietinck, AJ | 1 |
| Bailly, C; Cimanga, K; Claeys, M; Colson, P; De Pauw-Gillet, MC; Dommisse, R; Esmans, EL; Jonckers, TH; Lemière, F; Lemière, GL; Maes, L; Pieters, L; Quirijnen, L; Rozenski, J; van den Heuvel, H; van Miert, S; Vlietinck, A | 1 |
| Brun, R; Cos, P; Dhooghe, L; Dommisse, R; Hajós, G; Hostyn, S; Kaiser, M; Lemière, G; Maes, BU; Maes, L; Mátyus, P; Nagy, I; Pieters, L; Riedl, Z; Tapolcsányi, P; Van Baelen, G | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chadha, N; Silakari, O | 1 |
| Bharate, SB; Mudududdla, R; Nuthakki, VK | 1 |
| Hussain, T; Pati, S; Swain, SS | 1 |
| Bailly, C; Baldeyrou, B; Cimanga, K; Colson, P; De Pauw-Gillet, MC; Houssier, C; Laine, W; Pieters, L; Van Miert, S; Vlietinck, AJ | 1 |
| Bailly, C; Dassonneville, L; Lansiaux, A; Mahieu, C; Pieters, L; Van Miert, S; Wattelet, A; Wattez, N | 1 |
| Alberti, P; De Pauw, E; Gabelica, V; Guittat, L; Mergny, JL; Ottaviani, A; Pieters, L; Riou, JF; Rosu, F; Thetiot, E; Van Miert, S | 1 |
| Brun, R; Cimanga, K; Dommisse, R; Hostyn, S; Kaiser, M; Lemière, G; Maes, BU; Mátyus, P; Pieters, L; Van Miert, S; Vlietinck, A | 1 |
2 review(s) available for cryptolepine and neocryptolepine
| Article | Year |
|---|---|
Indoles as therapeutics of interest in medicinal chemistry: Bird's eye view.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Antiemetics; Antineoplastic Agents; Bacterial Infections; Chemistry, Pharmaceutical; Cholinergic Antagonists; Drug Discovery; Humans; Indoles; Migraine Disorders; Mycoses; Neoplasms; Virus Diseases | 2017 |
Role of basic aminoalkyl chains in the lead optimization of Indoloquinoline alkaloids.
Topics: Alkaloids; Antimalarials; Antineoplastic Agents; Cell Proliferation; Indoles; Malaria; Molecular Structure; Neoplasms; Quinolines | 2022 |
9 other study(ies) available for cryptolepine and neocryptolepine
| Article | Year |
|---|---|
In vitro and in vivo antiplasmodial activity of cryptolepine and related alkaloids from Cryptolepis sanguinolenta.
Topics: Alkaloids; Animals; Antimalarials; Humans; In Vitro Techniques; Indole Alkaloids; Indoles; Mice; Microbial Sensitivity Tests; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Quinolines; Spectrum Analysis | 1997 |
Synthesis, cytotoxicity, and antiplasmodial and antitrypanosomal activity of new neocryptolepine derivatives.
Topics: Alkaloids; Animals; Antimalarials; Cell Line; DNA; Heme; Hemin; Humans; Intercalating Agents; Plasmodium falciparum; Polymers; Quinolines; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship; Topoisomerase II Inhibitors; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosoma cruzi | 2002 |
Structure-activity relationship of antiparasitic and cytotoxic indoloquinoline alkaloids, and their tricyclic and bicyclic analogues.
Topics: Animals; Antimalarials; Antineoplastic Agents; Indole Alkaloids; Mice; Plasmodium berghei; Plasmodium falciparum; Structure-Activity Relationship | 2009 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Quinoline heterocyclic containing plant and marine candidates against drug-resistant Mycobacterium tuberculosis: A systematic drug-ability investigation.
Topics: Antitubercular Agents; Humans; Mycobacterium tuberculosis; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2022 |
DNA intercalation, topoisomerase II inhibition and cytotoxic activity of the plant alkaloid neocryptolepine.
Topics: Alkaloids; Animals; Antineoplastic Agents, Phytogenic; Cattle; Circular Dichroism; DNA; DNA Damage; DNA Footprinting; DNA Topoisomerases, Type II; Humans; Indole Alkaloids; Indoles; Intercalating Agents; KB Cells; Melanoma, Experimental; Mice; Mice, Inbred Strains; Plant Roots; Plants, Medicinal; Quinolines; Substrate Specificity; Topoisomerase II Inhibitors | 2000 |
Cytotoxicity and cell cycle effects of the plant alkaloids cryptolepine and neocryptolepine: relation to drug-induced apoptosis.
Topics: Alkaloids; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Caspases; Cell Cycle; Cell Survival; DNA Fragmentation; HL-60 Cells; Humans; Indole Alkaloids; Indoles; Leukemia P388; Mitochondria; Mitoxantrone; Poly(ADP-ribose) Polymerases; Quinolines | 2000 |
Interactions of cryptolepine and neocryptolepine with unusual DNA structures.
Topics: Alkaloids; Animals; Cryptolepis; DNA; Enzyme Inhibitors; Indole Alkaloids; Indoles; Mass Spectrometry; Nucleic Acid Conformation; Protein Binding; Quinolines; Structure-Activity Relationship; Substrate Specificity; Telomerase | 2003 |
Isoneocryptolepine, a synthetic indoloquinoline alkaloid, as an antiplasmodial lead compound.
Topics: Alkaloids; Animals; Antimalarials; Apocynaceae; Indole Alkaloids; Indoles; Molecular Structure; Plasmodium falciparum; Quinolines; Structure-Activity Relationship | 2005 |